WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareBiotechnology
Best Biotech Stocks to Buy Now (2023)
Top biotech stocks in 2023 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.

Industry: Biotechnology
Ticker
Company
Exchange
Industry
Zen Score
Market Cap
Price
1d %
EBITDA
P/E
D/E
XOMA
XOMA CORP
NASDAQ
Biotechnology
$243.22M$21.24-0.33%$18.98M23.87x0.12
GMAB
GENMAB A
NASDAQ
Biotechnology
$25.46B$38.68-0.31%$1.07B33.81x0.15
INCY
INCYTE CORP
NASDAQ
Biotechnology
$19.14B$86.011.22%$635.77M21.72x0.30
ITOS
ITEOS THERAPEUTICS INC
NASDAQ
Biotechnology
$791.55M$22.25-1.64%$350.77M3.00x0.23
TECH
BIO-TECHNE CORP
NASDAQ
Biotechnology
$12.61B$80.320.61%$460.14M43.18x0.34
VIR
VIR BIOTECHNOLOGY INC
NASDAQ
Biotechnology
$3.99B$29.99-2.76%$1.47B3.44x0.25
HRMY
HARMONY BIOSCIENCES HOLDINGS INC
NASDAQ
Biotechnology
$2.90B$48.82-1.73%$123.41M18.56x0.87
SIGA
SIGA TECHNOLOGIES INC
NASDAQ
Biotechnology
$548.41M$7.510.81%$139.65M5.18x0.18
PBYI
PUMA BIOTECHNOLOGY INC
NASDAQ
Biotechnology
$201.73M$4.42-3.70%$30.22M20.09x7.97
KNSA
KINIKSA PHARMACEUTICALS LTD
NASDAQ
Biotechnology
$957.45M$13.77-1.36%-$26.41M6.68x0.20
EXEL
EXELIXIS INC
NASDAQ
Biotechnology
$5.71B$17.712.19%$413.97M18.45x0.19
UTHR
UNITED THERAPEUTICS CORP
NASDAQ
Biotechnology
$12.04B$264.23-0.64%$987.80M16.93x0.27
CPRX
CATALYST PHARMACEUTICALS INC
NASDAQ
Biotechnology
$1.66B$15.99-4.42%$85.44M24.60x0.23
LPCN
LIPOCINE INC
NASDAQ
Biotechnology
$46.03M$0.521.17%$4.16M13.00x0.05
NBIX
NEUROCRINE BIOSCIENCES INC
NASDAQ
Biotechnology
$10.42B$108.38-0.39%$109.00M177.67x0.39
APVO
APTEVO THERAPEUTICS INC
NASDAQ
Biotechnology
$12.12M$2.38-0.42%$7.40M1.89x1.01
BMRN
BIOMARIN PHARMACEUTICAL INC
NASDAQ
Biotechnology
$21.74B$116.980.82%$220.15M259.96x0.37
BNTX
BIONTECH SE
NASDAQ
Biotechnology
$34.64B$142.54-0.13%$14.35B3.43x0.23
MRVI
MARAVAI LIFESCIENCES HOLDINGS INC
NASDAQ
Biotechnology
$3.54B$13.890.14%$362.93M7.63x2.79
HUMA
HUMACYTE INC
NASDAQ
Biotechnology
$268.11M$2.603.59%$48.48M0.88x0.91
MRNA
MODERNA INC
NASDAQ
Biotechnology
$74.24B$193.240.09%$13.68B6.58x0.45
EQRX
EQRX INC
NASDAQ
Biotechnology
$1.14B$2.340.43%-$145.24M1.16x0.10
TBPH
THERAVANCE BIOPHARMA INC
NASDAQ
Biotechnology
$718.79M$10.67-1.75%$1.08B0.95x0.59
ICPT
INTERCEPT PHARMACEUTICALS INC
NASDAQ
Biotechnology
$760.83M$18.37-0.97%$244.04M3.17x4.20
CMRX
CHIMERIX INC
NASDAQ
Biotechnology
$156.72M$1.78-2.20%$153.89M1.02x0.07
CBIO
CATALYST BIOSCIENCES INC
NASDAQ
Biotechnology
$9.57M$0.301.33%$12.22M0.80x0.06
XRTX
XORTX THERAPEUTICS INC
NASDAQ
Biotechnology
$8.99M$0.69-2.54%$1.84M1.82x0.40
EFTR
EFFECTOR THERAPEUTICS INC
NASDAQ
Biotechnology
$20.19M$0.48-1.43%$7.72M0.40x2.17
SELB
SELECTA BIOSCIENCES INC
NASDAQ
Biotechnology
$263.21M$1.720.58%$47.14M4.78x1.10
ACET
ADICET BIO INC
NASDAQ
Biotechnology
$380.95M$8.89-3.47%-$51.74M-6.22x0.12
ABCM
ABCAM PLC
NASDAQ
Biotechnology
$3.83B$16.75-1.12%$39.77M97.38x0.46
CSBR
CHAMPIONS ONCOLOGY INC
NASDAQ
Biotechnology
$54.91M$4.05-2.17%$2.20M405.00x2.97
DVAX
DYNAVAX TECHNOLOGIES CORP
NASDAQ
Biotechnology
$1.50B$11.78-0.25%$340.58M4.53x1.00
REGN
REGENERON PHARMACEUTICALS INC
NASDAQ
Biotechnology
$80.84B$742.300.15%$6.41B14.75x0.29
AVIR
ATEA PHARMACEUTICALS INC
NASDAQ
Biotechnology
$380.62M$4.571.56%$36.20M10.88x0.04
GRNA
GREENLIGHT BIOSCIENCES HOLDINGS PBC
NASDAQ
Biotechnology
$159.13M$1.051.94%-$149.47M0.04x0.79
AADI
AADI BIOSCIENCE INC
NASDAQ
Biotechnology
$313.97M$12.87-0.92%-$61.86M2.71x0.15
ABCL
ABCELLERA BIOLOGICS INC
NASDAQ
Biotechnology
$3.01B$10.521.06%$383.05M11.95x0.24
CDMO
AVID BIOSERVICES INC
NASDAQ
Biotechnology
$996.95M$16.000.69%$10.21M8.29x1.44
CORT
CORCEPT THERAPEUTICS INC
NASDAQ
Biotechnology
$2.47B$22.94-1.88%$129.75M21.24x0.13
VRTX
VERTEX PHARMACEUTICALS INC
NASDAQ
Biotechnology
$82.40B$321.021.82%$4.23B25.08x0.28
PULM
PULMATRIX INC
NASDAQ
Biotechnology
$14.52M$3.99-0.50%-$17.12M-0.57x0.33
LYRA
LYRA THERAPEUTICS INC
NASDAQ
Biotechnology
$85.93M$2.70-2.53%-$53.54M-0.97x0.28
AUPH
AURINIA PHARMACEUTICALS INC
NASDAQ
Biotechnology
$1.31B$9.211.77%-$110.58M-11.10x0.15
GNFT
GENFIT SA
NASDAQ
Biotechnology
$208.23M$4.180.48%$78.77M-0.22x1.37
XENE
XENON PHARMACEUTICALS INC
NASDAQ
Biotechnology
$2.39B$38.151.19%-$112.70M-19.56x0.03
ZLAB
ZAI LAB LTD
NASDAQ
Biotechnology
$4.35B$44.470.95%-$578.02M-7.13x0.17
VRDN
VIRIDIAN THERAPEUTICS INC
NASDAQ
Biotechnology
$1.51B$37.600.64%-$112.48M-10.42x0.08
HALO
HALOZYME THERAPEUTICS INC
NASDAQ
Biotechnology
$7.20B$53.281.51%$290.67M35.05x18.22
LUMO
LUMOS PHARMA INC
NASDAQ
Biotechnology
$29.90M$3.57-0.28%-$29.18M-1.05x0.17
AFMD
AFFIMED NV
NASDAQ
Biotechnology
$176.76M$1.200.84%-$81.53M-2.08x0.31
MRUS
MERUS NV
NASDAQ
Biotechnology
$682.97M$14.75-1.67%-$62.96M-10.31x0.39
RYTM
RHYTHM PHARMACEUTICALS INC
NASDAQ
Biotechnology
$1.72B$30.47-1.71%-$185.78M-8.49x0.39
XBIT
XBIOTECH INC
NASDAQ
Biotechnology
$136.98M$4.503.21%-$35.76M-3.78x0.03
KMPH
KEMPHARM INC
NASDAQ
Biotechnology
$182.19M$5.28-4.00%-$34.90M-1.86x0.28
BCYC
BICYCLE THERAPEUTICS PLC
NASDAQ
Biotechnology
$829.23M$27.93-0.11%-$96.58M-8.21x0.44
SNDX
SYNDAX PHARMACEUTICALS INC
NASDAQ
Biotechnology
$1.71B$28.333.51%-$10.40M944.33x0.06
IMAB
I-MAB
NASDAQ
Biotechnology
$512.57M$6.413.72%-$312.67M-1.60x0.24
VACC
VACCITECH PLC
NASDAQ
Biotechnology
$113.57M$3.053.57%$12.48M9.23x0.13
STTK
SHATTUCK LABS INC
NASDAQ
Biotechnology
$152.61M$3.600.84%-$65.96M-2.22x0.12
DCPH
DECIPHERA PHARMACEUTICALS INC
NASDAQ
Biotechnology
$1.22B$17.980.62%-$214.31M-5.20x0.27
ALT
ALTIMMUNE INC
NASDAQ
Biotechnology
$683.80M$13.91-0.86%-$86.86M-7.32x0.10
SESN
SESEN BIO INC
NASDAQ
Biotechnology
$124.49M$0.61-2.54%-$7.23M-61.40x0.21
PTGX
PROTAGONIST THERAPEUTICS INC
NASDAQ
Biotechnology
$648.44M$13.180.23%-$126.76M-4.92x0.16
HSTO
HISTOGEN INC
NASDAQ
Biotechnology
$4.40M$1.033.94%-$10.66M-0.25x0.34
CRDF
CARDIFF ONCOLOGY INC
NASDAQ
Biotechnology
$77.29M$1.730.58%-$39.19M-1.86x0.09
PALI
PALISADE BIO INC
NASDAQ
Biotechnology
$3.42M$2.22-3.48%-$9.27M0.25x0.31
VCNX
VACCINEX INC
NASDAQ
Biotechnology
$25.20M$0.591.72%-$19.18M-1.16x0.36
CGEM
CULLINAN ONCOLOGY INC
NASDAQ
Biotechnology
$510.36M$11.150.00%$149.51M4.79x0.05
SEER
SEER INC
NASDAQ
Biotechnology
$308.82M$4.93-0.80%-$83.98M-3.40x0.09
INMB
INMUNE BIO INC
NASDAQ
Biotechnology
$148.23M$8.260.73%-$31.14M-4.72x0.32
JANX
JANUX THERAPEUTICS INC
NASDAQ
Biotechnology
$916.59M$22.001.66%-$59.91M-15.49x0.13
RGNX
REGENXBIO INC
NASDAQ
Biotechnology
$995.75M$23.00-0.39%$123.83M12.64x0.57
ORTX
ORCHARD THERAPEUTICS PLC
NASDAQ
Biotechnology
$76.01M$0.603.81%-$174.72M-0.43x0.89
EDIT
EDITAS MEDICINE INC
NASDAQ
Biotechnology
$623.68M$9.07-0.22%-$199.58M-3.09x0.28
ATRA
ATARA BIOTHERAPEUTICS INC
NASDAQ
Biotechnology
$468.70M$4.942.49%-$234.48M-2.00x0.97
CASI
CASI PHARMACEUTICALS INC
NASDAQ
Biotechnology
$27.08M$1.990.00%-$23.98M-1.03x0.72
MIRM
MIRUM PHARMACEUTICALS INC
NASDAQ
Biotechnology
$873.09M$23.680.25%-$30.05M-21.14x1.15
MRNS
MARINUS PHARMACEUTICALS INC
NASDAQ
Biotechnology
$220.95M$5.94-0.34%-$2.82M-14.14x1.25
IMTX
IMMATICS NV
NASDAQ
Biotechnology
$512.60M$7.81-4.76%$44.90M13.80x2.13
VNDA
VANDA PHARMACEUTICALS INC
NASDAQ
Biotechnology
$435.18M$7.690.26%$13.07M59.15x0.21
ETON
ETON PHARMACEUTICALS INC
NASDAQ
Biotechnology
$92.08M$3.640.00%-$6.35M-10.40x0.93
NTLA
INTELLIA THERAPEUTICS INC
NASDAQ
Biotechnology
$3.04B$38.63-1.00%-$434.60M-6.57x0.32
BNTC
BENITEC BIOPHARMA INC
NASDAQ
Biotechnology
$6.44M$0.23-0.86%-$17.82M-10.95x0.24
AGIO
AGIOS PHARMACEUTICALS INC
NASDAQ
Biotechnology
$1.69B$30.72-0.19%-$345.96M-5.54x0.12
CLSD
CLEARSIDE BIOMEDICAL INC
NASDAQ
Biotechnology
$80.05M$1.330.76%-$4.41M-22.17x2.00
VYNE
VYNE THERAPEUTICS INC
NASDAQ
Biotechnology
$13.75M$0.243.04%-$25.03M-0.55x0.17
SAGE
SAGE THERAPEUTICS INC
NASDAQ
Biotechnology
$2.68B$44.971.03%-$509.19M-5.22x0.08
LPTX
LEAP THERAPEUTICS INC
NASDAQ
Biotechnology
$66.34M$0.673.88%-$53.24M-1.49x0.17
TCRT
ALAUNOS THERAPEUTICS INC
NASDAQ
Biotechnology
$150.90M$0.705.76%-$36.46M-3.49x1.10
FIXX
HOMOLOGY MEDICINES INC
NASDAQ
Biotechnology
$87.95M$1.53-1.92%$884.00k-19.13x0.26
FRTX
FRESH TRACKS THERAPEUTICS INC
NASDAQ
Biotechnology
$7.47M$2.480.81%-$22.56M-0.35x0.29
QURE
UNIQURE NV
NASDAQ
Biotechnology
$1.00B$21.39-0.97%-$108.56M-7.95x0.52
BLU
BELLUS HEALTH INC
NASDAQ
Biotechnology
$1.02B$8.080.75%-$49.18M-16.03x0.06
KDNY
CHINOOK THERAPEUTICS INC
NASDAQ
Biotechnology
$1.58B$24.76-4.48%-$103.17M-14.56x0.24
PGEN
PRECIGEN INC
NASDAQ
Biotechnology
$337.20M$1.62-1.82%$48.69M13.50x0.82
ACIU
AC IMMUNE SA
NASDAQ
Biotechnology
$202.71M$2.402.56%-$71.07M-2.70x0.08
DBVT
DBV TECHNOLOGIES SA
NASDAQ
Biotechnology
$248.23M$1.32-5.71%-$70.78M-2.44x0.17
CLGN
COLLPLANT BIOTECHNOLOGIES LTD
NASDAQ
Biotechnology
$124.28M$11.2112.89%-$15.50M-7.28x0.13
NRIX
NURIX THERAPEUTICS INC
NASDAQ
Biotechnology
$570.49M$12.10-2.89%-$159.48M-3.26x0.34

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Jan 2023?

According to Zen Score, the 3 best biotechnology stocks to buy right now are:

1. Xoma (NASDAQ:XOMA)


Xoma (NASDAQ:XOMA) is the top biotech stock with a Zen Score of 68, which is 40 points higher than the biotech industry average of 28. It passed 22 out of 33 due diligence checks and has strong fundamentals. Xoma has seen its stock return 5.51% over the past year, overperforming other biotech stocks by 16 percentage points.

Xoma has an average 1 year price target of $62.50, an upside of 194.26% from Xoma's current stock price of $21.24.

Xoma stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Xoma, 66.67% have issued a Strong Buy rating, 0% have issued a Buy, 33.33% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Genmab A (NASDAQ:GMAB)


Genmab A (NASDAQ:GMAB) is the second best biotech stock with a Zen Score of 68, which is 40 points higher than the biotech industry average of 28. It passed 23 out of 33 due diligence checks and has strong fundamentals. Genmab A has seen its stock return 18.22% over the past year, overperforming other biotech stocks by 29 percentage points.

Genmab A has an average 1 year price target of $38.35, a downside of -0.86% from Genmab A's current stock price of $38.68.

Genmab A stock has a consensus Hold recommendation according to Wall Street analysts. Of the 6 analysts covering Genmab A, 0% have issued a Strong Buy rating, 16.67% have issued a Buy, 66.67% have issued a hold, while 0% have issued a Sell rating, and 16.67% have issued a Strong Sell.

3. Iteos Therapeutics (NASDAQ:ITOS)


Iteos Therapeutics (NASDAQ:ITOS) is the third best biotech stock with a Zen Score of 66, which is 38 points higher than the biotech industry average of 28. It passed 21 out of 33 due diligence checks and has strong fundamentals. Iteos Therapeutics has seen its stock lose -37.02% over the past year, underperforming other biotech stocks by -27 percentage points.

Iteos Therapeutics has an average 1 year price target of $59.00, an upside of 165.17% from Iteos Therapeutics's current stock price of $22.25.

Iteos Therapeutics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Iteos Therapeutics, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 7 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Kineta (NASDAQ:KA)


Kineta (NASDAQ:KA) has an annual dividend yield of 127.84%, which is 97 percentage points higher than the biotech industry average of 31.3%.

Kineta's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

2. Catalyst Biosciences (NASDAQ:CBIO)


Catalyst Biosciences (NASDAQ:CBIO) has an annual dividend yield of 78.95%, which is 48 percentage points higher than the biotech industry average of 31.3%. Catalyst Biosciences's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Catalyst Biosciences's dividend has not shown consistent growth over the last 10 years.

Catalyst Biosciences's dividend payout ratio of 752.6% indicates that its high dividend yield might not be sustainable for the long-term.

3. Siga Technologies (NASDAQ:SIGA)


Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 5.99%, which is -25 percentage points lower than the biotech industry average of 31.3%.

Siga Technologies's dividend payout ratio of 31% indicates that its high dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -0.1% in the last day, and up 2.25% over the last week. Panbela Therapeutics was the among the top losers in the biotechnology industry, dropping -40.59% yesterday.

Panbela Therapeutics shares are trading lower after the company announced pricing of a roughly $15 million public offering at $2.75 per share.

What are the most undervalued biotech stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued biotech stocks right now are:

1. Eqrx (NASDAQ:EQRX)


Eqrx (NASDAQ:EQRX) is the most undervalued biotech stock based on WallStreetZen's Valuation Score. Eqrx has a valuation score of 100, which is 68 points higher than the biotech industry average of 32. It passed 7 out of 7 valuation due diligence checks.

Eqrx's stock has dropped -45.45% in the past year. It has underperformed other stocks in the biotech industry by -35 percentage points.

2. Aptevo Therapeutics (NASDAQ:APVO)


Aptevo Therapeutics (NASDAQ:APVO) is the second most undervalued biotech stock based on WallStreetZen's Valuation Score. Aptevo Therapeutics has a valuation score of 100, which is 68 points higher than the biotech industry average of 32. It passed 7 out of 7 valuation due diligence checks.

Aptevo Therapeutics's stock has dropped -56.88% in the past year. It has underperformed other stocks in the biotech industry by -47 percentage points.

3. Iteos Therapeutics (NASDAQ:ITOS)


Iteos Therapeutics (NASDAQ:ITOS) is the third most undervalued biotech stock based on WallStreetZen's Valuation Score. Iteos Therapeutics has a valuation score of 100, which is 68 points higher than the biotech industry average of 32. It passed 7 out of 7 valuation due diligence checks.

Iteos Therapeutics's stock has dropped -37.02% in the past year. It has underperformed other stocks in the biotech industry by -27 percentage points.

Are biotech stocks a good buy now?

49.86% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 71.32% over the next year.

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 12.81x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.